Skip to main content
Log in

Quetiapine: quite the contender in bipolar disorders

  • Meeting report
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

REFERENCE

  1. Ekman M, Lindgren P, Miltenburger C, Meier G, Locklear JC, Chatterton ML.Cost-effectiveness of quetiapine in patients with acute bipolar depression and in maintenance treatment after an acute depressive episode. 162nd Annual Meeting of the American Psychiatric Association: 151 abstr. NR4-045, 19 May 2009. Available from: URL: http://www.psych.org

  2. Tafesse E, Lazarus A.The cost-effectiveness of quetiapine as an adjunct to a mood stabilizer in the maintenance treatment of bipolar I disorder. 162nd Annual Meeting of the American Psychiatric Association: 175 abstr. NR4-107, 19 May 2009. Available from: URL: http://www.psych.org

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Quetiapine: quite the contender in bipolar disorders. Pharmacoecon. Outcomes News 581, 1 (2009). https://doi.org/10.2165/00151234-200905810-00001

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200905810-00001

Keywords

Navigation